Gut Liver.
2010 Dec;4(4):514-517.
A Planned Prospective, Randomized, Placebo-Controlled Multicenter Trial Assessing the Effect of Helicobacter pylori Eradication on the Healing of Iatrogenic Ulcer after Endoscopic Resection of Gastric Neoplasm
- Affiliations
-
- 1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. hyunchae@plaza.snu.ac.kr
- 2Department of Internal Medicine, Ulsan University College of Medicine, Seoul, Korea.
- 3Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
- 4Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.
- 5Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
- 6Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- 7Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
- 8Department of Preventive Medicine, Seoul National University College of Medicine and Medical Research Collaboration Center, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Korea.
- 9Korean College of Helicobacter and Upper Gastrointestinal Research, Seoul, Korea.
Abstract
- BACKGROUND/AIMS
Helicobacter pylori eradication may facilitate the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. This study involved designing a randomized, double-blinded, placebo-controlled, multicenter trial, performed by the Korean College of Helicobacter and Upper Gastrointestinal Research and the Medical Research Collaboration Center, Seoul National University Hospital.
METHODS
We intend to enroll up to 232 patients H.-pylori-positive patients who have gastric adenoma or early gastric cancer after endoscopic resection. The enrolled patients are being randomly allocated to the H.-pylori-eradication-plus-proton-pump-inhibitor group or the placebo-plus-proton-pump-inhibitor group based on their histology results and the size of the resected specimen. After random allocation, the iatrogenic ulcer size and stage are evaluated at 4- and 8-week follow-ups (with a window of +/-7 days). The primary end point is the healing rate of the ulcer by stage, and the secondary end point is the rate of ulcer size reduction, relief rate from ulcer-related symptoms, and adverse-event rates.
RESULTS
More than 90% of the target subjects have already been enrolled into the study and are receiving ongoing periodic monitoring by the Medical Research Collaboration Center.
CONCLUSIONS
Completion of the study should reveal whether H. pylori eradication can facilitate the healing of ulcer after endoscopic resection in Korea.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effectiveness of Helicobacter pylori Eradication before Endoscopic Resection
- Difference in Helicobacter pylori Eradication between Patients with Iatrogenic Ulcer after Endoscopic Resection and Patients with Peptic Ulcer
- Non-healing Iatrogenic Gastric Ulcers after Endoscopic Mucosal Resection for Gastric Epithelial Neoplasia: Report of Two Cases
- Helicobacter pylori Eradication in Patients with an Iatrogenic Ulcer after Endoscopic Resection and Peptic Ulcer
- Probiotic Supplementation for Treatment of Helicobacter pylori Infection: A Double-Blind Randomized Clinical Trial
